The growing demand for controlled immunological investigation and therapeutic development has spurred significant improvements in recombinant signal molecule production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently generated using multiple expression systems, including microbial hosts, higher cell culture